Acurex Biosciences
PrivateLast Round
Grant
May 27, 2026
Total Funding Raised
$2.52M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Acurex Biosciences is a biotechnology company that develops small-molecule medicines for the treatment of neurodegenerative diseases and movement disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acurex Biosciences Comparables
Compare Acurex Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arviat Pharmaceuticals, Inc. | 86% | |
| Praxis Precision Medicines, Inc. | 81% | |
| Vincere Biosciences | 80% | |
Acurex Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 27, 2026 | ||||
| Series A | May 27, 2026 | ||||
| Grant | Aug 7, 2024 | ||||
| Grant | Apr 27, 2022 | ||||
| Grant | Sep 30, 2021 | ||||
Grant | Aug 31, 2021 |
Acurex Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aligning Science Across Parkinson's (ASAP) | Grant |
| NIH RADx | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant, Seed |
| The Silverstein Foundation for Parkinson's with GBA | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Completed a Series A funding round.
- May 15, 2026
Monthly visitors increased 1524% MoM, reaching 2.2K.
Acurex Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Acurex Biosciences's valuation, stock price, and market status.